Pear Therapeutics, Inc.·4

Jan 18, 5:02 PM ET

Snow Ellen 4

4 · Pear Therapeutics, Inc. · Filed Jan 18, 2023

Insider Transaction Report

Form 4
Period: 2023-01-14
Snow Ellen
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-01-14+20,32031,345 total
  • Exercise/Conversion

    Restricted Stock Units

    2023-01-1420,32041,256 total
    Common Stock (20,320 underlying)
Footnotes (3)
  • [F1]Includes 11,025 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 30, 2022.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
  • [F3]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES